Sisällysluettelo:
“…Abstract
Background: Buprenorphine is used in the opioid maintenance treatment for opioid dependent patients, including pregnant women. …”
Sisällysluettelo:
“…Pichot -- Efficacy and safety of buprenorphine / Eric C. Strain, Gerard Iru I. Fernando -- Patient assessment / Petros Levounis, Jonathan Avery -- Clinical use of buprenorphine / Ricardo Restrepo, Petros Levounis -- Buprenorphine treatment in office-based settings / Jeffrey D. …”
Sisällysluettelo:
“…Abstract
Buprenorphine is a semi‐synthetic opioid, widely used in the maintenance treatment for opioid‐dependent pregnant women. …”
“…Injucting drug users in the Riski study Buprenorphine injecting has increased in poly-drug use Patients with dementia in open care guidelines for their care and follow-up…”
Sisällysluettelo:
“…Abstract
We describe the sudden death of a middle-aged man while having a sauna under the influence of α-pyrrolidinovalerophenone (α-PVP) (PM blood concentration: 0.8 mg/L), amphetamine (0.34 mg/L), and other drugs (buprenorphine, benzodiazepines), and engaging in solitary sexual activities. …”
Sisällysluettelo:
“…Melamine and nicotine increased CYP19A1, melamine increased UGT and GST, PhIP with ethanol decreased CYP19A1 and increased GST, and PhIP with buprenorphine decreased CAT. Antipyrine in 100 μg/ml also changed the studied enzyme activities, but not statistically significantly. …”
Sisällysluettelo:
“…3 Acute Pain Management of Opioid-Tolerant PatientsDefinitions; Assessment and monitoring; Aims of acute pain management in opioid-dependent patients; Management of patients on high-dose sublingual buprenorphine; References; Further reading; 4 Echocardiography and Anaesthesia; Before surgery; During surgery; After surgery and in critical care; Persistent unexplained hypotension; Persistent unexplained hypoxaemia; Future trends; Further reading; 5 Medico-Legal Aspects of Regional Anaesthesia; The pre-operative visit and consent; Preparation for the performance of regional anaesthesia…”
Sisällysluettelo:
“…Preface -- Chapter 1 Introduction -- Part I Strategic Issues and Frameworks -- Chapter 2 Setting the Stage: Today's Healthcare Challenges -- Chapter 3 Building Blocks for Strategic Planning -- Chapter 4 Tools for Transformational Strategic Planning -- Chapter 5 Driving Successful Implementation -- Part II Case Examples of Institutional Change: Hospitals, Treatment Centers, and Provider Groups -- Chapter 6 The Pursuit of the Integrated Multidisciplinary Service Line -- Chapter 7 Creating Ever Better Ways to Provide Cost-Effective Care for Our Community: The Costal Medical Journey -- Chapter 8 Transforming the Facility Master Planning Process: How to Manage Risk in Times of Uncertainty -- Part III Case Examples of Population Health Change -- Chapter 9 Buprenorphine Integrated Care Delivery Project: Genesis of the Howard University Urban Health Initiative -- Chapter 10 Transforming Cancer Survivorship Care -- Part IV Case Examples of Market Transformation -- Chapter 11 Importance of a Vision: Licensure of Medical Dosimetrists -- Chapter 12 Transforming Health Information Management: AHIMA and Scenario Planning -- Chapter 13 Transformation of Brand Planning to Embrace Future Uncertainties: A Pharmaceutical Company's Voyage -- Part V Concluding Remarks -- Chapter 14 Conclusion. …”
“…Most of the clients in the data identify alcohol as their principal opiate, but the data include users of cannabis, amphetamine and buprenorphine as well. Background information for this dataset included the following information based on the quantitative dataset: unique client number, date of client meeting, categorised age of the client, the client's gender, marital status, principal opiate and whether the client had children. …”
“…Most of the clients in the data identified alcohol as their principal opiate, but the data include users of cannabis, amphetamine and buprenorphine as well. Background information for this dataset included the following information based on the quantitative dataset: unique client number, date of client meeting, categorised age of the client, the client's gender, marital status, principal opiate and whether the client had children. …”